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OBJECTIVES: Hispanic colorectal cancer (CRC) rates historically have been lower than for non-Hispanic Whites in the United
States and in Florida. The aim of this study is to understand CRC trends in Florida Hispanics and non-Hispanic Whites.
METHODS: Using a cross-sectional study design, all invasive CRCs diagnosed among Florida residents between 1989 and 2006
were accessed from the Florida Cancer Data System (FCDS). These cases were analyzed by Hispanic and non-Hispanic White
ethnic identification. The Hispanic Origin Identification Algorithm was applied to the FCDS data to identify Hispanic subjects.
Primary cancer site and histology data were organized according to SEER (Surveillance Epidemiology and End Results)
categories. Joinpoint regression was used to generate incidence trends by stage and subsite location.
RESULTS: Rates of CRC incidence were higher for Florida Hispanics compared with non-Hispanic Whites since the mid 1990s.
There was a consistent significant increase in the incidence of distant stage CRC in Hispanics (annual percent change (APC) of
1.26 and 0.90 in males and females), whereas rates in non-Hispanics decreased significantly during the same time period (APC
1.36 and1.28, respectively). Similar trends were found in distant-stage right-sided CRC. Among right-sided CRCs, local stage
incidence rate increased for both non-Hispanic Whites and Hispanics, whereas the incidence rate for regional stage decreased
for both racial/ethnic groups.
CONCLUSIONS: Trends for distant-stage CRC are increasing among Florida Hispanics. This is a particular public health concern
given that CRC is a cancer for which screening modalities exist and could imply a concomitant increase in CRC-related mortality
among Florida Hispanics. Lower rates of CRC screening in Hispanics are documented at the state level, relative to non-Hispanic
Whites. Screening programs targeting the Florida Hispanic population are warranted.
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INTRODUCTION
In the United States, Hispanics are the largest, youngest, and
fastest-growing minority, accounting for 15% of the US
population (45.5 million people in 2007).1 In 2009, there were
four million Hispanics (21%) among Florida’s rapidly growing
population.2 Following California and Texas, Florida ranks
third among states with the highest number of Hispanics,
totaling over 3.7 million in 2007.3 Hispanics in the United
States have traditionally demonstrated lower cancer inci-
dence and mortality rates than non-Hispanic populations.4–6
Prior reports detailing colorectal cancer (CRC) incidence
trends in US Hispanics exist,7,8 but changes in this incidence
rate over time have not been well documented among
Hispanic subgroups. Detailing these potential changes is
important given the shift in lifestyle behaviors associated with
an increase in obesity and less nutritious diets among the
Hispanic population, particularly with increasing time spent in
the United States.9 Cancer occurrence and risk factors can
also vary among Hispanics because of acculturation, geo-
graphic, behavioral, and genetic differences.6,10–13 Ongoing
monitoring of CRC rates and trends in Hispanics is vital given
these demographic and behavioral shifts.
Despite their overall lower risk of cancer, US Hispanics are
more likely to be diagnosed at a later stage for certain
common cancers, and are less likely to report utilizing cancer
screening.14–16 In part, this may be because of a lack of health
insurance among Hispanics compared with non-Hispanic
Whites and Blacks; beyond access to care, other issues have
been identified as barriers to Hispanic cancer screening,
including less education, lower socioeconomic status, and
cultural barriers.14,16 Among FloridiansZ50 years old, based
on the 2008 Behavioral Risk Factor Surveillance Survey
(BRFSS), only 27.0% Hispanics compared with 49.8% non-
Hispanic Whites reported ever having home fecal blood
testing; only 49.5% vs. 67.7% reported ever having had
sigmoidoscopy or colonoscopy, respectively.17
Among Hispanics, lifestyle changes, relatively poor CRC
screening uptake, and the need for allocation of health dollars
underlie the need for identification of trends in CRC incidence.
The aim of this study is to examine the 1986–2006 trends in
CRC incidence among Hispanics residing within Florida by
using data from the Florida Cancer Data System (FCDS)
registry, the second largest central cancer registry in the
United States. This investigation differs from prior studies by
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representation of a diversity of Hispanic nationalities and by
the factors contributing to increased CRC burden among this
population. The Hispanic population of Florida differs from
prior studies in that it includes not only Hispanics of Central
American origin, but also from the Caribbean islands
(including Cuba, Puerto Rico, and the Dominican Republic)
and Central/South American countries.3 A special emphasis
on trends in advanced-stage cancer stratified by region of
colonic involvement has been performed given recent atten-
tion to this topic in the gastrointestinal and oncologic literature.
METHODS
Data were derived from all cancer cases among Hispanic and
non-Hispanic White Florida residents, diagnosed between
1989 and 2006, and reported to the FCDS (n¼ 178,927). The
FCDS is a statewide, population-based cancer incidence
registry created by the State of Florida Department of Health in
1978, and operated by the Sylvester Comprehensive Cancer
Center at the University of Miami Leonard M. Miller School of
Medicine with support from the Florida Department of Health
and from the Centers for Disease Control and Prevention
(CDC) and National Program for Cancer Registries (NPCR).
For the assignment of ethnicity and subpopulation, the
recently developed Hispanic Origin Identification Algorithm
(HOIA) was used, using data from the FCDS.12 HOIA is largely
based on the existing North American Association of Central
Cancer Registries (NAACCR) Hispanic Identification Algorithm
(NHIA).18 HOIA takes into account all information routinely
available to cancer registries, and in addition, all non-Hispanic
cases are matched to a Hispanic surname list.19 HOIA is
available online at http://fcds.med.miami.edu and has been
described in detail in previous publications.10–12,20 A compar-
ison between results from HOIA and NHIA has been
performed.10,11,20 In short, HOIA corrects for data miscodes
common in the FCDS database in the NAACCR data item 190
‘‘Hispanic Origin,’’ for example, misclassification of unknown
Hispanics as ‘‘Mexican,’’ or the inclusion of Brazilians and
Portuguese as Hispanics. In addition, HOIA uses a stepwise
approach to incorporate the information present in death
certificates (birthplace and recorded Hispanic subgroup) with
the same information from cancer registry records. Not only
does HOIA provide increased ascertainment of Hispanic
ethnicity, it also allows for estimates of cancer rates in the
following Hispanic subpopulations: Mexicans, Puerto Ricans,
Cubans, and New Latinos (all other Hispanics).13 Of note, HOIA
was not able to reclassify all Hispanics into these subpopula-
tions; in this case, these Hispanics were categorized as a
subgroup denoted as ‘‘Hispanic NOS’’ or ‘‘not otherwise
classified.’’
The rates presented were focused on Hispanics and the
comparison group of non-Hispanic Whites, that is, a mixed
ethnic and racial classification. ‘‘Hispanics’’ include both
Blacks and Whites in part because this follows the patterns
of Hispanic race/ethnic self-identification (i.e., Black Hispa-
nics often identify as ‘‘Hispanics’’ rather than ‘‘Black’’), and
because the numbers of identified Black Hispanics in the
FCDS database are quite small. These analyses do not
include non-Hispanic Blacks who are a mixture of African
Americans and Blacks from other countries (particularly the
Caribbean). As with all data in the FCDS, these racial/ethnic
data are extracted from the medical and pathology records by
trained Certified Cancer Registrars using nationally recog-
nized standards.21 Reported cases of malignant CRC
diagnosed among Florida residents of all races and ethnicities
during the 18-year period from 1989 to 2006 were used in the
analysis. Primary cancer site and histology data were coded
according to the International Classification of Diseases for
Oncology in use at the time of diagnosis, converted to the third
edition.22 Colorectal classification included all sites coded
C18.0 through C20.9. Approximately 90% of all colorectal
carcinomas were classified as adenocarcinomas, historically
the most common histologic type. Subsite locations were
categorized into the right colon (cecum, ascending colon,
hepatic flexure, and transverse colon), the left colon (splenic
flexure, descending colon, and sigmoid colon), and the rectum
(rectosigmoid junction, rectum). Staging was derived from the
1977 and 2000 Surveillance Epidemiology and End Results
(SEER) coding systems,23 of which our analysis included the
following staging categories: local, regional, and distant. This
research specifically analyzed distant-stage CRC, which
refers to a case where cells have spread beyond the colon
and rectum, the primary tumor, to other parts of the body.
These extensions can occur in the lymph nodes beyond those
closest to the colon and rectum, or in organs beyond the
adjacent tissue of the colon and rectum. Local- and regional-
stage CRCs were also considered.
Age- and gender-specific population data for the state of
Florida for each racial and ethnic group for the study years
were obtained from the Florida Consensus Estimating Con-
ference for the underlying denominator of all individuals at
risk.24 Cancer incidence rates for years 1989–2006 per
100,000 persons were age adjusted by 18 age groups (0–4,
5–9,y, 80–84, andZ85) to the 2000 US standard population.
The direct method of age adjustment was used to calculate
age-adjusted incidence and mortality rates.25 Standard errors
and 95% confidence intervals were generated using equations
published by SEER*Stat.26 These values were produced to
enable long-term cancer incidence trends through Joinpoint
analysis for all Hispanics and non-Hispanic Whites.27 To
protect confidentiality, data were suppressed when cell counts
wereo10 cancer cases (following FCDS rules).
The analyses of cancer incidence trends between the years
1989–2006 were conducted using the Joinpoint regression
model, where statistically significant rate changes (increase or
decrease) determine the best fitting points, or ‘‘joinpoints.’’
The analysis begins with a minimum number of joinpoints
(e.g., zero or a straight line), and tests whether one or more
points are significant and whether they should be added to the
model by means of the Monte Carlo Permutation method. The
final model represents a statistically significant change in a
trend at each joinpoint. The annual percent change (APC), or
the average rate of change in a cancer rate, was generated for
each joinpoint segment and was tested at the Po0.05 to
determine if the rate of change was significantly different from
zero. A maximum of three joinpoints and four line segments
were allowed for each model. The joinpoint analyses were
performed using the Joinpoint software, version 3.3, from the
Surveillance Research Program of the US National Cancer
Institute (available at http://srab.cancer.gov/joinpoint).
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The following are the results of the joinpoint analyses of
CRC among Hispanics over the 1989–2006 time period,
comparing Hispanic males and females with non-Hispanic
White males and females by stage and subsite location.
RESULTS
Demographics. The Hispanic population described herein
comprised individuals of a variety of Caribbean, Mexican,
and Central and South American origins, as delineated by
US 2000 Census data (Table 1). The majority of Florida
Hispanics are of Cuban ancestry (31%). The proportion of
CRCs during years 1989–2006 among Hispanics in Florida is
reflective of this finding, with 44% of CRCs identified in
patients of Cuban origin.
CRC trends by gender and ethnicity. The age-adjusted
rates of CRC changed substantially over the time period;
ultimately, Hispanic males had the highest rates (2006: 56
cases/100,000) compared with non-Hispanic White males
(2006: 50 cases/100,000), and Hispanic females had higher
rates (2006: 41 cases/100,000) than non-Hispanic White
females (2006: 37 cases/100,000). Initially, both male and
female Hispanics had significant increases in CRC trends,
males in particular, with an APC of 4.01 (between 1989 and
1996), and women with an APC of 1.05 (between 1989 and
2000). The increase in rates for Hispanic males was
particularly large from 1989 to 1996, eliminating the lower
relative difference in rates with non-Hispanic males. There
were overall decreasing trends in CRC incidence for both
Hispanic and non-Hispanic Whites (Figure 1). Rates among
non-Hispanic Whites began decreasing at a rate of 1.09 for
males (1989–2000) and 0.65 for females (1989–2000) from
the start of the study period. This decline among non-
Hispanic Whites continued to decline at a greater rate until
2006 (4.47 non-Hispanic males and 4.01 non-Hispanic
females). A similar decline occurred in Hispanics, although
not until the late 1990s and early 2000s, with a more
pronounced downward trend among females (4.19) than in
males (2.69). All trends were statistically significant.
CRC trends by local, regional, and distant stage. Incidence
rate trends for CRC by stage vary by time period, race/
ethnicity, and sex. For local-stage disease, there were no
significant rate changes among Hispanic males or females,
whereas non-Hispanic White males and females experienced
initial declines (3.76 and 3.20, respectively) up to the mid
1990s, at which point changes became insignificant. By 2006,
incidence rates were comparable between males, and
between females of both groups. With the exception of a
significant increase in regional-stage CRC among Hispanic
men (2.67) in the early period, there were significant declining
trends for all groups beginning from the early 2000s, with APCs
ranging from 5.93 for Hispanic males and 7.36 for non-
Hispanic White females. By the end of the period, Hispanics
had slightly higher rates than non-Hispanic Whites. For distant-
stage (Figure 2) CRC, only non-Hispanic White males
and females experienced significant declines throughout the
study period (1.36 and 1.28, respectively), whereas
significantly increasing rates occurred among Hispanic males
and females (1.26 and 0.90, respectively), resulting in higher
overall rates in 2006 compared with their non-Hispanic White
counterparts.
Distant-stage CRC trends by subsite colonic location. The
alarming finding of increased incidence rate of distant-stage
CRC prompted an investigation for specific colonic locations of
disparate disease burden. An analysis of CRC trends by
distant stage and subsite colonic location produced similar
variations by race/ethnicity and sex (Table 2). Distant-stage
trends in the right colon (Figure 3) produced overall increasing
Table 1 Proportions of CRC incidence rates by Hispanic subgroup in relation to
proportion of Hispanic population
Country of
origin
Proportion by
US 2000 census (%)
Proportion of CRC,
1989–2006 (%)
Cuba 31 44
Puerto Rico 17 8
Mexico 14 2
South and Central
America
19 7
Other Hispanic 19 10
Hispanic NOS — 29
CRC, colorectal cancer; NOS, not otherwise classified.
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Figure 1 Joinpoint regression trends for colorectal cancer, Florida, 1989–2006.
APC, annual percent change; NH, non-Hispanic. *Statistical significance Po0.05.
4
5
6
7
8
9
10
11
12
Male Hispanic Male NH White Female Hispanic Female NH White
Rates per 100,000
Annual Percent Change (APC)
*Statistical Significance P<0.05
APC 1.26*
APC 0.9*
APC -1.36*
APC -1.28*
20052001 20031995 1997 1999199319911989
Figure 2 Joinpoint regression trends for colorectal cancer, distant stage,
Florida, 1989–2006. APC, annual percent change; NH, non-Hispanic. *Statistical
significance Po0.05.
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rates among Hispanic males and females (2.04 and 2.19,
respectively), whereas after an initial increase among non-
Hispanic White males until 1994 (3.15), overall decreasing
trends occurred among non-Hispanic White males and females
(2.39 and 1.34, respectively).
Distant-stage trends in the left colon resulted in overall
declines throughout the time period, although trends were
significant only among non-Hispanic White males and
females (2.1 and 2.0, respectively). Results for distant-
stage cancer of the rectum show significant declines among
non-Hispanic White males and females (1.31 and 1.52,
respectively), but there were no significant changes among
Hispanic males or females during this time period.
Trends for local and regional stages of CRC by subsite
colonic location. Left-sided CRC trends among non-
Hispanic White males and females have significantly
declined overall since 1986 for all stages (local 5.8 and
5.3; regional 8.3 and 7.7; distant 2.1 and 2.0 male
and female, respectively; Table 3). Male and female
Hispanics experienced a significant decline in left-sided
colon cancer for regional stage only (8.9 and 2.4).
Local-stage right-sided CRC increased significantly for both
Hispanic and non-Hispanic Whites (Hispanic 2.3 and 5.6; non-
Hispanic White 0.9 and 1.4; Table 4). Regional-stage CRC
decreased significantly among Hispanic and non-Hispanic
White males and females (Hispanic 8.6 and 6.9; non-
Hispanic White 7.9 and 7.9).
DISCUSSION
This investigation identified a concerning trend for the
increased incidence rate of distant-stage CRC among Florida
Hispanics. This finding is of particular importance given the
precipitous drop in survival noted for distant-stage disease
when compared with local or regional CRC.28 According to the
most recent US Census data, Hispanics comprise the largest
proportion of growth among the US population, giving the
present findings immediate importance with regard to health
policy.29
Florida has the third largest Hispanic population in the
United States, with a diverse distribution of Hispanic
subgroups compared with other states.3 This diversity is
based not only on self-reported country of origin or distinct
sociocultural behaviors, but also on genomic observations.
Study of genome patterns among US Hispanics from the
Caribbean and South America reveal significant variation in
admixture proportions, reflective of a history of human
migration.30 These genomic markers delineate a wide range
of ancestral contribution among US Hispanics, with mixture of
Native American, European, and African origins. Genomic
differences in the proportions of continental ancestry are
noticed among Hispanic countries of origin, particularly
when comparing Mexicans with Caribbean Hispanic popula-
tions (i.e., Cuban and Puerto Rican).31 Furthermore,
differences in gene frequency among US Hispanics categor-
ized by country of origin have been associated with
noncancer-related disease risk.32 Clinical data demonstrate
that Hispanic subpopulations do have discrete cancer
risks, with Caribbean (Puerto Rican) Hispanics having higher
cancer risk than Mexicans.13 Perhaps this cancer difference
by country of origins for US Hispanics is mediated by genomic
differences representing distinct proportions of admixed
heritage.
These observations make the current analysis of Hispanic
cancer incidence unique to the region, but raise intriguing
questions regarding advanced stage of CRC presentation and
CRC disease location that may be applicable to the more
generalizable population of Hispanics as a whole, in particular
for regions where Caribbean or South American Hispanics
predominate. Since the 1990s, cancer incidence rates among
both female and male Hispanics in Florida have dropped
steadily, and have historically been lower than rates among
Table 2 Joinpoint regression results for distant-stage colorectal cancer: subsite
by sex and race/ethnicity, Florida, 1989–2006
Sex Joinpoint
segment
APC
Distant colon and rectum
Hispanic Male 1989 2006 1.26a
Female 1989 2006 0.90a
NH White Male 1989 2006 1.36a
Female 1989 2006 1.28a
Distant-stage left colon
Hispanic Male 1989 2006 0.14
Female 1989 2006 0.79
NH White Male 1989 2006 2.14a
Female 1989 2006 1.97a
Distant-stage right colon
Hispanic Male 1989 2006 2.04a
Female 1989 2006 2.19a
NH White Male 1989 1994 3.15
1994 2006 2.39a
Female 1989 2006 1.34a
Distant-stage rectum
Hispanic Male 1989 2006 0.62
Female 1989 2006 0.56
NH White Male 1989 2006 1.31a
Female 1989 2006 1.52a
APC, annual percent change; NH, non-Hispanic. aAPC is statistically significant
at Po0.05.
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Figure 3 Joinpoint regression trends for right colon cancer, distant stage,
Florida, 1989–2006. APC, annual percent change; NH, non-Hispanic. *Statistical
significance Po0.05.
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the non-Hispanic White population.33 Similar trends were
observed in incidence rates of CRC, where declines among
Hispanics have occurred since the late 1990s; however, CRC
incidence rates were higher in Hispanics than non-Hispanic
Whites in Florida by the year 2006.
The rationale underlying this observed difference in
incidence rates is unclear, but may be multifactorial. The
rapidity with which the trends have developed suggests a
population-level influence like domestic and international
migration patterns rather than an underlying biologic or
cultural distinction that would take decades to manifest. The
US Census 2000 showed that the southern states, including
Florida, experienced the largest net domestic immigration
gain of Hispanics during the period 1995–2000, with 92,480
Hispanics moving primarily from New York, New Jersey, and
California.34 Hispanics also make up the majority of movers to
the United States from abroad, with 348,477 immigrating to
Florida.34 These population fluxes may underlie the observed
incidence rate changes.
CRC screening behaviors may explain another portion of
these findings. It is unclear from the data available within the
FCDS whether the subjects had previously undergone any
CRC screening before diagnosis. One explanation for the
increase in distant-stage and distant-stage right-sided colon
carcinoma among Hispanics may be the persistently low rate
of CRC screenings in Florida. In 2002, only 35% of Hispanics
over the age of 50 reported having received either a
sigmoidoscopy or colonoscopy exam in the previous 5 years
compared with 47% of non-Hispanic Whites.35 In 2008, those
figures increased slightly to 42% for Hispanics and 59% for
non-Hispanic Whites.36 Factors previously documented to be
associated with poor utilization of CRC screening include lack
of health insurance coverage, foreign-born status, duration of
residency in the United States, language preference, and
attitudinal fears; these characteristics are common among the
Hispanic population of Florida.37–39
Although the overall downward trends in CRC incidence
noted in this study are encouraging, the relationship between
Table 3 Left-sided colon trends by stage, sex, and race/ethnicity, Florida, 1989–2006
Stage Sex Cohort Segment Year from Year to APC Lower CI Upper CI
Local Male Hispanic 1 1989 2006 1 2.4 0.4
Local Male Non-Hispanic White 1 1989 1995 5.8* 8.9 2.6
Local Male Non-Hispanic White 2 1995 1999 5.1 4.9 16.2
Local Male Non-Hispanic White 3 1999 2006 3.5* 5.9 1
Local Female Hispanic 1 1989 2006 0.8 2.6 1
Local Female Non-Hispanic White 1 1989 1996 5.3* 6.6 4
Local Female Non-Hispanic White 2 1996 2000 5.4* 0 11
Local Female Non-Hispanic White 3 2000 2006 4.0* 5.8 2.3
Regional Male Hispanic 1 1989 1999 3.1 0.6 6.9
Regional Male Hispanic 2 1999 2006 8.9* 13.8 3.7
Regional Male Non-Hispanic White 1 1989 2000 1.9* 2.8 1.1
Regional Male Non-Hispanic White 2 2000 2006 8.3* 10.6 6
Regional Female Hispanic 1 1989 2006 2.4* 3.8 1
Regional Female Non-Hispanic White 1 1989 2000 1.7* 2.8 0.6
Regional Female Non-Hispanic White 2 2000 2006 7.7* 10.6 4.7
Distant Male Hispanic 1 1989 2006 0.1 1.6 1.9
Distant Male Non-Hispanic White 1 1989 2006 2.1* 2.9 1.4
Distant Female Hispanic 1 1989 2006 0.8 2.6 1
Distant Female Non-Hispanic White 1 1989 2006 2.0* 2.6 1.3
APC, annual percent change; CI, confidence interval. Left-sided colon trends among non-Hispanic White males and females have significantly declined overall since
1986 for all stages. Male and female Hispanics experienced a significant decline in left colon cancer for regional stage only. *Statistical significance Po0.05.
Table 4 Right-sided colon trends by stage, sex, and race/ethnicity, Florida, 1989–2006
Stage Sex Cohort Segment Year from Year to APC Lower CI Upper CI
Local Male Hispanic 1 1989 2006 2.3* 1.1 3.5
Local Male Non-Hispanic White 1 1989 1992 7.6 15.4 1
Local Male Non-Hispanic White 2 1992 2006 0.9* 0.1 1.6
Local Female Hispanic 1 1989 1999 5.6* 2.9 8.4
Local Female Hispanic 2 1999 2006 1.8 4.8 1.4
Local Female Non-Hispanic White 1 1989 2006 1.4* 0.9 2
Regional Male Hispanic 1 1989 2001 1 1.4 3.3
Regional Male Hispanic 2 2001 2006 8.6* 15 1.7
Regional Male Non-Hispanic White 1 1989 2000 0.5 1.5 0.6
Regional Male Non-Hispanic White 2 2000 2006 7.9* 10.5 5.2
Regional Female Hispanic 1 1989 2001 1.2 0.6 3
Regional Female Hispanic 2 2001 2006 6.9* 12.1 1.4
Regional Female Non-Hispanic White 1 1989 2000 0.3 0.5 1.2
Regional Female Non-Hispanic White 2 2000 2006 7.9* 10 5.8
APC, annual percent change; CI, confidence interval. Local-stage right colon cancer increased significantly for both Hispanic and non-Hispanic (NH) Whites, whereas
regional stage decreased significantly among Hispanic and NH White males and females. *Statistical Significance Po0.05.
Trends in Colorectal Cancer Among Florida Hispanics
Hernandez et al.
5
Clinical and Translational Gastroenterology
cancer prognosis and degree of cancer progression at
diagnosis warrant analysis of CRC characteristics by stage
of disease. The 5-year survival rate for CRC is 90% when
diagnosed at local stage and 11.6% when diagnosed at
distant stage.40 Analyzing trends by stage is an important
indicator of both the burden of advanced disease and the
likelihood of mortality secondary to CRC. Although Hispanics
traditionally have lower rates of cancer incidence and
mortality, they have higher rates of advanced-stage cancers
than their Non-Hispanic White counterpart for many types of
cancers, as was noted in this study.15
In Florida, local-stage CRC among Hispanics increased
since 1989, although these trends were not statistically
significant, whereas rates for regional CRC declined signifi-
cantly since the late 1990s for both males and females. In
contrast, distant-stage CRC rates among Hispanic males and
females increased at a steady and statistically significant rate
over the study period, surpassing the incidence rates of non-
Hispanic Whites in the mid to late 1990s. Distant-stage trends
in the left colon resulted in overall declines throughout the
period for Hispanics and non-Hispanics. However, declines
were only significant among the non-Hispanic White popula-
tion. Similar trends were found for distant-stage rectal cancer.
Distant-stage trends in the right colon increased among
Hispanic males and females at a steady and significant rate,
whereas trends declined significantly for Non-Hispanic
Whites since 1989 for females and since the early 1990s for
males. Right-colon cancer trends in the US Hispanic popula-
tion have not shown the same increase in rates as those in
the Florida Hispanic population.41,42 However, Mexican
Hispanics are the overwhelming majority in the national
studies, unlike Florida Hispanics where Cubans are the
predominant subgroup.
For those individuals fortunate enough to have access to
the formal health care system, screening modalities confer a
CRC-specific survival benefit, particularly when fecal occult
blood testing is performed and followed by endoscopic
investigation for positive test results.43,44 But given the
increase in screening rates among Florida Hispanics over
time, we would have expected to see an attenuation of
increasing trends in advanced-stage right-sided colon cancer;
this was not observed. Sigmoidoscopy and colonoscopy are
suboptimal in detecting and preventing proximal colon
cancers. A recent, large-scale study of British patients
promotes the utility of once-only flexible sigmoidoscopy as
screening to prevent CRC.45 Screening colonoscopy is
associated with a decreased mortality from CRC in observa-
tional studies, but this survival benefit is more pronounced for
distal colonic neoplasias than proximal lesions.46,47 The
reason for the disparate rate of endoscopic CRC detection/
benefit by colonic region may be multifactorial, including its
significant miss rate.48–51 Many clinicians suspect that the
exaggerated miss rate in the proximal colon may be related to
the different endoscopic and histologic appearance of right-
sided colonic neoplasias.51–53 The utility of colonoscopy
should continue to increase with the recognition of quality
indicators for the procedure and advances in intraprocedural
technologies to improve polyp detection.
Addressing sociocultural barriers, improving access to CRC
screening modalities, and improvement in existing screening
procedures are important, but may not entirely explain
underlying differences in CRC epidemiology between
Hispanics and non-Hispanic Whites. The disparity in cancer
exists not only at the population level, but may also exist at
the molecular/genetic level. Confronting these differences
in tumor biology is vital in alleviating their influence on
health-care disparities and screening test outcomes.
Increasing attention has been paid to the different biology
between right- and left-side lesions as well as variance by
ethnicity.54–56 Poorly understood is the role of ethnic
variability in molecular markers and their potential role in
CRC disease outcome and late stage at diagnosis; this gap
in knowledge exists because few studies address the
molecular mechanism of CRC in minority populations.
Minority populations in particular are disproportionately
diagnosed with right-sided colon cancers.57,58 Microsatel-
lite instability is also more likely to occur in cancers of the
right colon than the left colon and rectum.59 These findings
support the future investigation of microsatellite instability
in Florida Hispanics.60
Prior investigations do not support the notion of an
increased prevalence of proximal colonic neoplasia in
Hispanics. A review of SEER data that segregated groups
by race and ethnicity notes that Hispanics develop fewer
CRCs in the proximal colon than non-Hispanic Whites or
Blacks.61 In fact, Hispanic Americans develop distal CRCs
more frequently and at an earlier age than the population at
large.62 Although Blacks in the United States are commonly
diagnosed with proximal colon malignancies, this is not true
for US Hispanics.63 American Blacks commonly, but not
universally, demonstrate a preponderance of proximal colonic
lesions.64,65
Although the FCDS has received Gold Certification from the
NAACCR since 2003, all cancer registry data can be limited by
the accuracy and completeness of the data. Staging data are
not always complete, and cancer records from the Florida
Veteran’s Administration medical facilities are not included. In
the present study, this could exclude a number of Puerto
Rican patients who utilize the Veteran’s Administration
system. In addition, the denominator data used to calculate
incidence rates were based on US Census estimates, which
can also be subject to inaccuracies. Application of the HOIA
algorithm to the FCDS data has reduced misclassification of
Hispanic subgroups, but it must be acknowledged that
misclassification of Hispanic subgroups still occurs. Also,
the lack of annual census estimates for Hispanic subgroups
within Florida prevented us from calculating cancer incidence
estimates for our pooled data.
In summary, trends in colorectal rates have declined
significantly for both Hispanics and non-Hispanic Whites in
Florida since the 1990s. However, rate trends for distant-
stage CRC increased significantly among male and female
Florida Hispanics, whereas rates decreased among non-
Hispanic Whites. Similar patterns were observed when
analyzing distant-stage rates in the right-sided colon; overall
decreasing trends occurred among non-Hispanic White males
and females whereas increasing trends were observed
among male and female Hispanics. Variations in effective
screening modalities, screening compliance, and access to
insurance for screening coverage could play a significant role
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in producing these trends. Moreover, scientific investigations
of molecular markers are warranted to fully understand the
biological mechanisms behind varying trends in distant-stage
and right-sided CRC.
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Study Highlights
WHAT IS CURRENT KNOWLEDGE
| Hispanic CRC incidence is traditionally believed to
be lower than non-Hispanic White counterparts.
| In the US Hispanics are less likely to participate
in CRC screening.
WHAT IS NEW HERE
| Distant-stage CRC is increasing among Florida
Hispanics.
| The ethnic disparity for incidence of distant-stage
CRC originating in the right colon continued to
widen during the study period.
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